Literature DB >> 19549780

Coupling of ionic events to protein kinase signaling cascades upon activation of alpha7 nicotinic receptor: cooperative regulation of alpha2-integrin expression and Rho kinase activity.

Alexander I Chernyavsky1, Juan Arredondo, Jing Qian, Valentin Galitovskiy, Sergei A Grando.   

Abstract

Defining the signaling mechanisms and effector proteins mediating phenotypic and mechanical plasticity of keratinocytes (KCs) during wound epithelialization is one of the major goals in epithelial cell biology. The acetylcholine (ACh)-gated ion channels, or nicotinic ACh receptors (nAChRs), mediate the nicotinergic signaling that controls crawling locomotion of KCs. To elucidate relative contributions of the ionic and protein kinase-mediated events elicited due to activation of alpha7 nAChRs, we quantitated expression of alpha2-integrin gene at the mRNA and protein levels and also measured Rho kinase activity in KCs stimulated with the alpha7 agonist AR-R17779 while blocking the Na+ or Ca2+ entry and/or inhibiting signaling kinases. The results demonstrated the existence of the two-component signaling systems coupling the ionic events and protein kinase signaling cascades downstream of alpha7 nAChR to simultaneous up-regulation of alpha2-integrin expression and activation of Rho kinase. The Raf/MEK1/ERK1/2 cascade up-regulating alpha2-integrin was activated due to both Ca2+-dependent recruitment of Ca2+/calmodulin-dependent protein kinase II and protein kinase C and Ca2+-independent activation of Ras. Likewise the phosphatidylinositol 3-kinase-mediated activation of Rho kinase was elicited due to both Ca2+ entry-dependent involvement of Ca2+/calmodulin-dependent protein kinase II and Ca2+-independent activation of Jak2. Thus, although the initial signals emanating from activated alpha7 nAChR are different in nature the pathways intersect at common effector molecules providing for a common end point effect. This novel paradigm of nAChR-mediated coordination of the ionic and metabolic signaling events can allow an auto/paracrine ACh to simultaneously alter gene expression and induce reciprocal changes in the cytoskeleton and contractile system of KCs required to compete a particular step of wound epithelialization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19549780      PMCID: PMC2755938          DOI: 10.1074/jbc.M109.011395

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Phosphoinositide 3-kinases in cell migration.

Authors:  Robert J Cain; Anne J Ridley
Journal:  Biol Cell       Date:  2009-01       Impact factor: 4.458

2.  Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis.

Authors:  R L Sorenson; L E Stout
Journal:  Endocrinology       Date:  1995-09       Impact factor: 4.736

3.  alpha-Bungarotoxin-sensitive hippocampal nicotinic receptor channel has a high calcium permeability.

Authors:  N G Castro; E X Albuquerque
Journal:  Biophys J       Date:  1995-02       Impact factor: 4.033

4.  Identification of Ras farnesyltransferase inhibitors by microbial screening.

Authors:  M Hara; K Akasaka; S Akinaga; M Okabe; H Nakano; R Gomez; D Wood; M Uh; F Tamanoi
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

Review 5.  Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans.

Authors:  I Wessler; C J Kirkpatrick
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

6.  Effects of SK&F 96365, an inhibitor of receptor-mediated Ca2+ entry, on Ca2+ influx and catecholamine secretion in bovine adrenal chromaffin cells.

Authors:  E Tachikawa; S Takahashi; K Mizuma; Y Kondo; T Kashimoto; E Takahashi
Journal:  Neurosci Lett       Date:  1994-08-15       Impact factor: 3.046

7.  Inability of Ca2+ influx through nicotinic ACh receptor channels to stimulate catecholamine secretion in bovine adrenal chromaffin cells: studies with fura-2 and SBFI microfluorometry.

Authors:  M Sorimachi; S Nishimura; K Yamagami
Journal:  Jpn J Physiol       Date:  1994

8.  Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium.

Authors:  P Séguéla; J Wadiche; K Dineley-Miller; J A Dani; J W Patrick
Journal:  J Neurosci       Date:  1993-02       Impact factor: 6.167

9.  Receptor-mediated tobacco toxicity: acceleration of sequential expression of alpha5 and alpha7 nicotinic receptor subunits in oral keratinocytes exposed to cigarette smoke.

Authors:  Juan Arredondo; Alexander I Chernyavsky; David L Jolkovsky; Kent E Pinkerton; Sergei A Grando
Journal:  FASEB J       Date:  2008-05       Impact factor: 5.834

10.  Monovalent and divalent cation permeability and block of neuronal nicotinic receptor channels in rat parasympathetic ganglia.

Authors:  T J Nutter; D J Adams
Journal:  J Gen Physiol       Date:  1995-06       Impact factor: 4.086

View more
  11 in total

1.  Novel cholinergic peptides SLURP-1 and -2 regulate epithelialization of cutaneous and oral wounds.

Authors:  Alexander I Chernyavsky; Mina Kalantari-Dehaghi; Courtney Phillips; Steve Marchenko; Sergei A Grando
Journal:  Wound Repair Regen       Date:  2011-12-13       Impact factor: 3.617

2.  Nicotinic receptor signaling in nonexcitable epithelial cells: paradigm shifting from ion current to kinase cascade. Focus on "Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases".

Authors:  Andrzej Slominski
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-25       Impact factor: 4.249

3.  Burn Injury Alters Epidermal Cholinergic Mediators and Increases HMGB1 and Caspase 3 in Autologous Donor Skin and Burn Margin.

Authors:  Casey J Holmes; Jennifer K Plichta; Richard L Gamelli; Katherine A Radek
Journal:  Shock       Date:  2017-02       Impact factor: 3.454

4.  Keratinocyte nicotinic acetylcholine receptor activation modulates early TLR2-mediated wound healing responses.

Authors:  Mari Kishibe; Tina M Griffin; Katherine A Radek
Journal:  Int Immunopharmacol       Date:  2015-06-10       Impact factor: 4.932

5.  Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases.

Authors:  Alexander I Chernyavsky; Juan Arredondo; Valentin Galitovskiy; Jing Qian; Sergei A Grando
Journal:  Am J Physiol Cell Physiol       Date:  2010-07-21       Impact factor: 4.249

6.  Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors.

Authors:  Alexander I Chernyavsky; Juan Arredondo; Maryna Skok; Sergei A Grando
Journal:  Int Immunopharmacol       Date:  2009-12-18       Impact factor: 4.932

7.  Chronic nicotine exposure stimulates biliary growth and fibrosis in normal rats.

Authors:  Kendal Jensen; Syeda Afroze; Yoshiyuki Ueno; Kinan Rahal; Amber Frenzel; Melanie Sterling; Micheleine Guerrier; Damir Nizamutdinov; David E Dostal; Fanyin Meng; Shannon S Glaser
Journal:  Dig Liver Dis       Date:  2013-04-13       Impact factor: 4.088

Review 8.  Connections of nicotine to cancer.

Authors:  Sergei A Grando
Journal:  Nat Rev Cancer       Date:  2014-05-15       Impact factor: 60.716

9.  α7-nAChR Activation Has an Opposite Effect on Healing of Covered and Uncovered Wounds.

Authors:  Jiao-Yong Li; Shu-Kun Jiang; Lin-Lin Wang; Meng-Zhou Zhang; Shuai Wang; Zhen-Fei Jiang; Yu-Li Liu; Hao Cheng; Miao Zhang; Rui Zhao; Da-Wei Guan
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

10.  Mitochondria express α7 nicotinic acetylcholine receptors to regulate Ca2+ accumulation and cytochrome c release: study on isolated mitochondria.

Authors:  Galyna Gergalova; Olena Lykhmus; Olena Kalashnyk; Lyudmyla Koval; Volodymyr Chernyshov; Elena Kryukova; Victor Tsetlin; Sergiy Komisarenko; Maryna Skok
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.